Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$299.84
-4.40-1.45%
al cierre: -
$300.02
0.180.06%
After hour: 6:43 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
UnitedHealth Group Inc ha un obiettivo di prezzo di consenso pari a $408.17, stabilito in base alle ultime valutazioni degli analisti di 25. Le ultime 3 valutazioni degli analisti sono state rilasciate da Morgan Stanley, B of A Securities y Mizuho il agosto 20, 2025, agosto 18, 2025 y agosto 7, 2025. Con un obiettivo di prezzo medio di $316.67 tra le Morgan Stanley, B of A Securities y Mizuho, c'è un implicito 5.55% upside per UnitedHealth Group Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Morgan Stanley
B of A Securities
Mizuho
JP Morgan
Wells Fargo
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para UnitedHealth Group
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/20/2025 | 8.33% | Morgan Stanley | $342 → $325 | Maintains | Overweight | |||
08/18/2025 | 8.33% | B of A Securities | $290 → $325 | Maintains | Neutral | |||
08/07/2025 | -0.01% | Mizuho | $350 → $300 | Maintains | Outperform | |||
08/06/2025 | 3.33% | JP Morgan | $418 → $310 | Maintains | Overweight | |||
08/04/2025 | -11.01% | Wells Fargo | $306 → $267 | Maintains | Overweight | |||
07/31/2025 | -34% | Baird | $312 → $198 | Downgrade | Neutral → Underperform | |||
07/30/2025 | -4.67% | RBC Capital | $355 → $286 | Maintains | Outperform | |||
07/30/2025 | 8.33% | Oppenheimer | $400 → $325 | Maintains | Outperform | |||
07/30/2025 | 16.66% | Keybanc | $400 → $350 | Maintains | Overweight | |||
07/30/2025 | 5.66% | Piper Sandler | $353 → $317 | Maintains | Overweight | |||
07/30/2025 | -3.34% | B of A Securities | $300 → $290 | Maintains | Neutral | |||
07/29/2025 | -0.01% | B of A Securities | $350 → $300 | Maintains | Neutral | |||
07/25/2025 | 1.99% | Wells Fargo | $351 → $306 | Maintains | Overweight | |||
07/16/2025 | 14.99% | Truist Securities | $360 → $345 | Maintains | Buy | |||
07/09/2025 | 12.33% | Barclays | $350 → $337 | Maintains | Overweight | |||
06/25/2025 | 28.32% | UBS | $400 → $385 | Maintains | Buy | |||
06/20/2025 | 39.32% | JP Morgan | $405 → $418 | Maintains | Overweight | |||
06/11/2025 | 3.99% | Baird | $356 → $312 | Downgrade | Outperform → Neutral | |||
06/03/2025 | 17.66% | Piper Sandler | $552 → $353 | Maintains | Overweight | |||
06/02/2025 | 16.66% | Barclays | $362 → $350 | Maintains | Overweight | |||
06/02/2025 | 33.32% | Keybanc | $450 → $400 | Maintains | Overweight | |||
05/21/2025 | -10.01% | HSBC | $490 → $270 | Downgrade | Hold → Reduce | |||
05/20/2025 | 29.99% | Wolfe Research | $501 → $390 | Maintains | Outperform | |||
05/19/2025 | 2.66% | TD Securities | $520 → $308 | Downgrade | Buy → Hold | |||
05/19/2025 | 19.99% | Truist Securities | $580 → $360 | Reiterates | Buy → Buy | |||
05/16/2025 | 16.66% | Mizuho | $515 → $350 | Maintains | Outperform | |||
05/16/2025 | 18.33% | RBC Capital | $525 → $355 | Maintains | Outperform | |||
05/15/2025 | 20.66% | Barclays | $513 → $362 | Maintains | Overweight | |||
05/15/2025 | 34.99% | JP Morgan | $525 → $405 | Maintains | Overweight | |||
05/14/2025 | 20.66% | Deutsche Bank | $521 → $362 | Maintains | Buy | |||
05/14/2025 | 33.32% | Oppenheimer | $600 → $400 | Maintains | Outperform | |||
05/14/2025 | 16.99% | Wells Fargo | $677 → $351 | Maintains | Overweight | |||
05/14/2025 | 24.66% | Morgan Stanley | $563 → $374 | Maintains | Overweight | |||
05/14/2025 | 16.66% | B of A Securities | $560 → $350 | Downgrade | Buy → Neutral | |||
05/14/2025 | 18.66% | Baird | $510 → $356 | Maintains | Outperform | |||
05/14/2025 | 49.99% | Keybanc | $575 → $450 | Maintains | Overweight | |||
05/13/2025 | 83.99% | Piper Sandler | $552 → $552 | Maintains | Overweight | |||
05/06/2025 | 71.66% | Mizuho | $650 → $515 | Maintains | Outperform | |||
04/29/2025 | 69.99% | Baird | $640 → $510 | Maintains | Outperform | |||
04/24/2025 | 70.99% | Barclays | $560 → $513 | Maintains | Overweight | |||
04/24/2025 | 74.99% | JP Morgan | $652 → $525 | Maintains | Overweight | |||
04/23/2025 | 74.99% | RBC Capital | $655 → $525 | Maintains | Outperform | |||
04/22/2025 | 63.32% | HSBC | $595 → $490 | Downgrade | Buy → Hold | |||
04/22/2025 | 87.65% | Morgan Stanley | $664 → $563 | Maintains | Overweight | |||
04/21/2025 | — | Argus Research | — | Downgrade | Buy → Hold | |||
04/21/2025 | 93.32% | Truist Securities | $660 → $580 | Maintains | Buy | |||
04/21/2025 | 86.65% | Barclays | $642 → $560 | Maintains | Overweight | |||
04/21/2025 | 91.65% | Keybanc | $650 → $575 | Maintains | Overweight | |||
04/21/2025 | 79.99% | Raymond James | $635 → $540 | Reiterates | Strong Buy → Strong Buy | |||
04/21/2025 | 99.99% | Oppenheimer | $640 → $600 | Maintains | Outperform | |||
04/11/2025 | 119.99% | Truist Securities | $610 → $660 | Maintains | Buy | |||
04/09/2025 | 116.65% | Mizuho | $600 → $650 | Maintains | Outperform | |||
01/28/2025 | 119.99% | Wells Fargo | $694 → $660 | Maintains | Overweight | |||
01/17/2025 | 113.99% | Barclays | $655 → $642 | Maintains | Overweight | |||
01/17/2025 | 116.65% | Keybanc | $650 → $650 | Reiterates | Overweight → Overweight | |||
01/17/2025 | 133.32% | Cantor Fitzgerald | $700 → $700 | Reiterates | Overweight → Overweight | |||
01/06/2025 | 103.32% | Truist Securities | $625 → $610 | Maintains | Buy | |||
01/02/2025 | 99.99% | Piper Sandler | $605 → $600 | Maintains | Overweight | |||
12/06/2024 | 113.32% | Oppenheimer | $610 → $640 | Maintains | Outperform | |||
12/05/2024 | 124.99% | Stephens & Co. | $605 → $675 | Maintains | Overweight | |||
12/03/2024 | 108.32% | Deutsche Bank | $595 → $625 | Maintains | Buy | |||
11/27/2024 | 118.32% | Barclays | $603 → $655 | Maintains | Overweight | |||
10/22/2024 | 100.99% | Barclays | $604 → $603 | Maintains | Overweight | |||
10/18/2024 | 102.99% | TD Cowen | $601 → $609 | Maintains | Buy | |||
10/16/2024 | 116.65% | UBS | $680 → $650 | Maintains | Buy | |||
10/16/2024 | 101.65% | Stephens & Co. | $632 → $605 | Maintains | Overweight | |||
10/16/2024 | 114.65% | Cantor Fitzgerald | $591 → $644 | Maintains | Overweight | |||
10/16/2024 | 108.32% | Truist Securities | $640 → $625 | Reiterates | Buy → Buy | |||
10/16/2024 | 98.32% | RBC Capital | $615 → $595 | Maintains | Outperform | |||
10/16/2024 | 116.65% | Keybanc | $675 → $650 | Maintains | Overweight | |||
10/16/2024 | 103.32% | Morgan Stanley | $615 → $610 | Maintains | Overweight | |||
10/16/2024 | 116.65% | B of A Securities | $675 → $650 | Maintains | Buy | |||
10/11/2024 | 124.99% | Keybanc | → $675 | Initiates | → Overweight | |||
10/01/2024 | 96.99% | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
09/20/2024 | 96.99% | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
09/16/2024 | 96.99% | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
09/10/2024 | 96.99% | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
08/19/2024 | 96.99% | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
07/23/2024 | 96.99% | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
07/18/2024 | 126.65% | UBS | $640 → $680 | Maintains | Buy | |||
07/17/2024 | 99.99% | Argus Research | $570 → $600 | Maintains | Buy | |||
07/17/2024 | 100.32% | TD Cowen | $546 → $601 | Maintains | Buy | |||
07/17/2024 | 101.32% | Barclays | $560 → $604 | Maintains | Overweight | |||
07/17/2024 | 96.99% | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
07/17/2024 | 109.99% | Wells Fargo | $525 → $630 | Maintains | Overweight | |||
07/17/2024 | 113.32% | Truist Securities | $600 → $640 | Maintains | Buy | |||
07/17/2024 | 104.99% | RBC Capital | $555 → $615 | Maintains | Outperform | |||
07/17/2024 | 115.65% | Jefferies | $481 → $647 | Upgrade | Hold → Buy | |||
07/17/2024 | 113.32% | Baird | $597 → $640 | Maintains | Outperform | |||
07/17/2024 | 104.99% | Morgan Stanley | $595 → $615 | Maintains | Overweight | |||
07/09/2024 | 96.99% | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
06/12/2024 | 96.99% | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
05/30/2024 | 86.32% | JP Morgan | $546 → $559 | Maintains | Overweight | |||
05/30/2024 | 98.99% | Baird | → $597 | Initiates | → Outperform | |||
04/19/2024 | 87.32% | Deutsche Bank | $545 → $562 | Maintains | Buy | |||
04/17/2024 | 99.99% | Truist Securities | → $600 | Reiterates | Buy → Buy | |||
04/17/2024 | 84.99% | RBC Capital | $596 → $555 | Maintains | Outperform | |||
04/17/2024 | 86.65% | Barclays | $534 → $560 | Maintains | Overweight | |||
04/17/2024 | 90.32% | Piper Sandler | $566 → $571 | Maintains | Overweight | |||
04/10/2024 | 96.99% | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de UnitedHealth Group (UNH)?
El último precio objetivo de UnitedHealth Group (NYSE:UNH) fue comunicado por Morgan Stanley el agosto 20, 2025. La firma de analistas fijó un precio objetivo para $325.00 que espera UNH a rise dentro de 12 meses (un posible 8.33% upside). 77 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre UnitedHealth Group (UNH)?
La última calificación de analistas para UnitedHealth Group (NYSE:UNH) fue proporcionada por Morgan Stanley, y UnitedHealth Group mantuvo su overweight calificación.
¿Cuándo se produjo la última revisión al alza de UnitedHealth Group (UNH)?
La última revisión al alza de UnitedHealth Group Inc se produjo en julio 17, 2024, cuando Jefferies elevó su precio objetivo a $647. Jefferies anteriormente tenía a hold para UnitedHealth Group Inc.
¿Cuándo fue la última revisión a la baja de UnitedHealth Group (UNH)?
La última revisión a la baja de UnitedHealth Group Inc se produjo en julio 31, 2025, cuando Baird cambió su precio objetivo de $312 a $198 para UnitedHealth Group Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para UnitedHealth Group (UNH)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de UnitedHealth Group, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de UnitedHealth Group se registró el agosto 20, 2025, por lo que la próxima calificación estará disponible en torno al agosto 20, 2026.
¿Es correcta la calificación de los analistas sobre UnitedHealth Group (UNH)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de UnitedHealth Group (UNH) fue un mantuvo con un precio objetivo de $342.00 a $325.00. El precio actual al que cotiza UnitedHealth Group (UNH) es de $300.02, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.